Company overview
Terumo Blood and Cell Technologies provides medical technologies for blood collection, processing, and cell-based therapies, including apheresis systems, blood bags, and automated cell expansion solutions like the Quantum system. They support hospitals, blood centers, researchers, and cell therapy developers with products for whole blood separation, pathogen reduction, and CAR-T cell manufacturing. Their offerings enhance efficiency in therapeutic apheresis and enable scalable cell and gene therapies globally.
Terumo Blood And Cell Technologies is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include terumo bct, blood collection, cell therapy, car-t manufacturing, apheresis systems, quantum system.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.terumobct.com
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- terumo bct, blood collection, cell therapy, car-t manufacturing, apheresis systems, quantum system
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What are Terumo BCT's key capabilities in cell therapy manufacturing?
- They offer automated systems like the Quantum Cell Expansion System for T cell activation, lentiviral transduction, and CAR-T cell expansion, achieving over 12 billion cells in 7-8 days with doubled transduction efficiency.
- What regulatory standards do Terumo BCT products meet?
- Their solutions support high-quality care for blood transfusions and advanced therapies, with a focus on standards for quality, efficiency, and patient access in hospitals, blood centers, and cell therapy development.
- In which geographies does Terumo BCT operate?
- They provide global support, including a dedicated C> Ecosystem Blueprint for the Asia-Pacific region, alongside operations in North America and worldwide for blood and cell technologies.
Related editorial coverage
- Allogene CEO David Chang Steps Down: Implications for the Biotech Sector
- Cencora-Kite Agreement: A New Era for CAR T-cell Therapy Commercialization
- Legend Biotech's In Vivo CAR-T Data Sparks Stock Surge: A Catalyst Tracking Analysis
- Legend Biotech Presents Promising CARVYKTI and LB2102 Data at ASCO
- ASGCT: Key Manufacturing Innovations Day 1
- ASGCT 2024: Gene Therapy Advancements Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
